192 related articles for article (PubMed ID: 10095179)
1. Effect of the platelet-derived growth factor antagonist trapidil on mesangial cell proliferation in rats.
Futamura A; Izumino K; Nakagawa Y; Takata M; Inoue H; Iida H
Nephron; 1999; 81(4):428-33. PubMed ID: 10095179
[TBL] [Abstract][Full Text] [Related]
2. Trapidil modifies mesangial cell proliferation and collagen accumulation in anti-thymocyte serum (ATS)-induced glomerulonephritis.
Razzaque MS; Cheng M; Taguchi T
J Comp Pathol; 1996 Feb; 114(2):175-82. PubMed ID: 8920217
[TBL] [Abstract][Full Text] [Related]
3. Trapidil inhibits human mesangial cell proliferation: effect on PDGF beta-receptor binding and expression.
Gesualdo L; Di Paolo S; Ranieri E; Schena FP
Kidney Int; 1994 Oct; 46(4):1002-9. PubMed ID: 7861694
[TBL] [Abstract][Full Text] [Related]
4. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
[TBL] [Abstract][Full Text] [Related]
5. PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis.
Gilbert RE; Kelly DJ; McKay T; Chadban S; Hill PA; Cooper ME; Atkins RC; Nikolic-Paterson DJ
Kidney Int; 2001 Apr; 59(4):1324-32. PubMed ID: 11260393
[TBL] [Abstract][Full Text] [Related]
6. Counteractive effects of HGF on PDGF-induced mesangial cell proliferation in a rat model of glomerulonephritis.
Bessho K; Mizuno S; Matsumoto K; Nakamura T
Am J Physiol Renal Physiol; 2003 Jun; 284(6):F1171-80. PubMed ID: 12595276
[TBL] [Abstract][Full Text] [Related]
7. Suppression of mesangial-cell proliferation by trapidil in glomerulonephritis induced by anti-thymocyte serum in rats.
Razzaque MS; Cheng M; Taguchi T
J Int Med Res; 1995; 23(6):458-66. PubMed ID: 8746613
[TBL] [Abstract][Full Text] [Related]
8. Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats.
Floege J; Eng E; Young BA; Alpers CE; Barrett TB; Bowen-Pope DF; Johnson RJ
J Clin Invest; 1993 Dec; 92(6):2952-62. PubMed ID: 7902849
[TBL] [Abstract][Full Text] [Related]
9. Effect of simvastatin on proliferative nephritis and cell-cycle protein expression.
Yoshimura A; Nemoto T; Sugenoya Y; Inui K; Watanabe S; Inoue Y; Sharif S; Yokota N; Uda S; Morita H; Ideura T
Kidney Int Suppl; 1999 Jul; 71():S84-7. PubMed ID: 10412745
[TBL] [Abstract][Full Text] [Related]
10. Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
Panichi V; Migliori M; Taccola D; Filippi C; De Nisco L; Giovannini L; Palla R; Tetta C; Camussi G
Kidney Int; 2001 Jul; 60(1):87-95. PubMed ID: 11422740
[TBL] [Abstract][Full Text] [Related]
11. Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis.
Floege J; Eng E; Young BA; Couser WG; Johnson RJ
Kidney Int; 1993 Feb; 43(2):369-80. PubMed ID: 8441232
[TBL] [Abstract][Full Text] [Related]
12. Thrombospondin peptides are potent inhibitors of mesangial and glomerular endothelial cell proliferation in vitro and in vivo.
Hugo CP; Pichler RP; Schulze-Lohoff E; Pröls F; Adler S; Krutsch HC; Murphy-Ullrich JE; Couser WG; Roberts DD; Johnson RJ
Kidney Int; 1999 Jun; 55(6):2236-49. PubMed ID: 10354272
[TBL] [Abstract][Full Text] [Related]
13. Caveolae in mesangial cells and caveolin expression in mesangial proliferative glomerulonephritis.
Tamai O; Oka N; Kikuchi T; Koda Y; Soejima M; Wada Y; Fujisawa M; Tamaki K; Kawachi H; Shimizu F; Kimura H; Imaizumi T; Okuda S
Kidney Int; 2001 Feb; 59(2):471-80. PubMed ID: 11168929
[TBL] [Abstract][Full Text] [Related]
14. SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits platelet-derived-growth-factor-medicated mesangial cell proliferation in vitro.
Pichler RH; Bassuk JA; Hugo C; Reed MJ; Eng E; Gordon KL; Pippin J; Alpers CE; Couser WG; Sage EH; Johnson RJ
Am J Pathol; 1996 Apr; 148(4):1153-67. PubMed ID: 8644857
[TBL] [Abstract][Full Text] [Related]
15. Endothelin modulates the mitogenic effect of PDGF on glomerular mesangial cells.
Kohno M; Horio T; Yokokawa K; Yasunari K; Kurihara N; Takeda T
Am J Physiol; 1994 Jun; 266(6 Pt 2):F894-900. PubMed ID: 8023969
[TBL] [Abstract][Full Text] [Related]
16. Dissociation of mesangial cell migration and proliferation in experimental glomerulonephritis.
Haseley LA; Hugo C; Reidy MA; Johnson RJ
Kidney Int; 1999 Sep; 56(3):964-72. PubMed ID: 10469364
[TBL] [Abstract][Full Text] [Related]
17. The effect of lovastatin on proliferation of cultured rat mesangial and aortic smooth muscle cells.
Choi KH; Kang SW; Lee SW; Lee HY; Han DS; Kang BS
Yonsei Med J; 1995 Jul; 36(3):251-61. PubMed ID: 7660676
[TBL] [Abstract][Full Text] [Related]
18. Tranilast inhibits the effects of platelet-derived growth factor on cell proliferation and induction of nitric oxide.
Hishikawa K; Nakaki T; Hirahashi J; Marumo T; Saruta T
Eur J Pharmacol; 1995 Nov; 291(3):435-8. PubMed ID: 8719431
[TBL] [Abstract][Full Text] [Related]
19. Modulation of experimental mesangial proliferative nephritis by interferon-gamma.
Johnson RJ; Lombardi D; Eng E; Gordon K; Alpers CE; Pritzl P; Floege J; Young B; Pippin J; Couser WG
Kidney Int; 1995 Jan; 47(1):62-9. PubMed ID: 7731171
[TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenic compound (TNP-470) inhibits mesangial cell proliferation in vitro and in vivo.
Haraguchi M; Okamura M; Konishi M; Konishi Y; Negoro N; Inoue T; Kanayama Y; Yoshikawa J
Kidney Int; 1997 Jun; 51(6):1838-46. PubMed ID: 9186873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
